David A. Lynch, MD William D. Travis, MD Nestor L. Muller, MD, PhD Jeffrey R. Galvin, MD David M. Hansell, MD Philippe A. Grenier, MD Talmadge E. King, Jr, MD Published online

untitledconsensus-based in 2000 to evidence-based in 2011 G. Raghu I diopathic pulmonary fibrosis (IPF) is increasingly recog- nised as a well-known clinical and highly complex

Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumoniasava i lab le at www.sc iencedi rect .com journal homepage : www.e lsev ie r . com/

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society A

© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2016;8(12):3711-3719jtd.amegroups.com Introduction Idiopathic pulmonary fibrosis (IPF) is a very specific